Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nanjing Vazyme Biotech Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nanjing Vazyme Biotech Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.08.
Nanjing Vazyme Biotech Co (SHSE:688105) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nanjing Vazyme Biotech Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nanjing Vazyme Biotech Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nanjing Vazyme Biotech Co Days Inventory Related Terms
Nanjing Vazyme Biotech Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688105 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Nanjing Vazyme Biotech Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Vazyme Biotech Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanjing Vazyme Biotech Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nanjing Vazyme Biotech Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Vazyme Biotech Co (SHSE:688105) has a Days Inventory of 341.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nanjing Vazyme Biotech Co and its competitors. This is 25% above median its historical median of 273.55. Over the past decade, Nanjing Vazyme Biotech Co's Days Inventory has ranged from 99.65 to 354.90. According to the industry distribution chart, Nanjing Vazyme Biotech Co ranks #447 out of 637 companies in the Biotechnology industry, placing it in the top 70.2%.
Is Nanjing Vazyme Biotech Co's Days Inventory too high?
Nanjing Vazyme Biotech Co's current Days Inventory of 341.52 is 25% above median its 10-year median of 273.55. Over the past 10 years, this metric has ranged from a low of 99.65 to a high of 354.90. The Biotechnology industry median Days Inventory is 183.16. Nanjing Vazyme Biotech Co's value of 341.52 is 86.5% above this industry median. Based on the distribution chart, Nanjing Vazyme Biotech Co ranks #447 out of 637 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nanjing Vazyme Biotech Co has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Vazyme Biotech Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanjing Vazyme Biotech Co ranks #447 out of 637 companies for Days Inventory. This places Nanjing Vazyme Biotech Co in the lower half of its industry. The industry median Days Inventory is 183.16. Nanjing Vazyme Biotech Co's value of 341.52 is 86.5% above this benchmark. Historically, Nanjing Vazyme Biotech Co's own Days Inventory has ranged from 99.65 to 354.90 over the past decade. While the company's 10-year median is 273.55 vs. the industry median of 183.16, Nanjing Vazyme Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.16, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Vazyme Biotech Co's current Days Inventory of 341.52 is 86.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nanjing Vazyme Biotech Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Vazyme Biotech Co's current Days Inventory is 341.52, which is 25% above median its own 10-year median of 273.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Vazyme Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Vazyme Biotech Co (SHSE:688105) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.72, compared to a current price of ¥17.64 — trading 0.5% below its estimated fair value. The current Days Inventory is 341.52, which is 25% above median its 10-year median of 273.55 and 86.5% above the Biotechnology industry median of 183.16. Nanjing Vazyme Biotech Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nanjing Vazyme Biotech Co (SHSE:688105), the current Days Inventory is 341.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Vazyme Biotech Co (SHSE:688105) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Vazyme Biotech Co stock appears to be undervalued.
The current stock price of ¥17.64 is trading 0.5% below its estimated GF Value™ of ¥17.72.
GuruFocus considers Nanjing Vazyme Biotech Co to be Fairly Valued.
Key valuation signals for SHSE:688105:
Days Inventory: 341.52 (25% above median its 10-year median of 273.55)
GF Value™: ¥17.72 vs. price of ¥17.64 (0.5% below fair value)
Industry Position: 86.5% above the Biotechnology median (#447 of 637)
No single metric tells the full story. See the SHSE:688105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressKechuang Road, Floor 1-6, East Section, Building C1-2, Hongfeng Science and Technology Park, Jiangsu, Economic and Technological Development Zone, Nanjing, CHN, 210000
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
72GF Score
Get the complete analysis for SHSE:688105
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688105 has been successfully added to your 
